Patent details
EP2841092 Title: COMPOUNDS AND COMPOSITIONS FOR USE IN A METHOD OF TREATMENT OF PARAINFLUENZA VIRUS
Basic Information
- Publication number:
- EP2841092
- PCT Application Number:
- US2013026754
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP137493292
- PCT Publication Number:
- WO2013123521
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMPOUNDS AND COMPOSITIONS FOR USE IN A METHOD OF TREATMENT OF PARAINFLUENZA VIRUS
- French Title of Invention:
- COMPOSÉS ET COMPOSITIONS POUR UTILISATION DANS UNE MÉTHODE DE TRAITEMENT DU VIRUS PARAINFLUENZA
- German Title of Invention:
- VERBINDUNGEN UND ZUSAMMENSETZUNGEN ZUR ANWENDUNG IN EINEM VERFAHREN ZUR BEHANDLUNG EINES PARAINFLUENZAVIRUS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 04/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 09/01/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 06/12/2023
- Unitary Effect Registration Date:
- 09/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/02/2013
- Grant date:
- 06/12/2023
- EP Publication Date:
- 04/03/2015
- PCT Publication Date:
- 22/08/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/12/2023
- EP B1 Publication Date:
- 06/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/02/2033
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 29/11/2023
- Name:
- Ansun Biopharma, Inc.
- Address:
- 10045 Mesa Rim Road, San Diego, CA 92121, United States (US)
Inventor
1
- Name:
- MOSS, Ron
- Address:
- United States (US)
2
- Name:
- LI, Tiejun
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201261600545 P
- Priority Date:
- 17/02/2012
- Priority Country:
- United States (US)
2
- Priority Number:
- 201261727627 P
- Priority Date:
- 16/11/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/47; A61K 31/16; A61P 11/12; A61K 9/00; A61P 11/00; A61P 31/14; A61P 31/16; A61P 43/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202349
- Publication date:
- 06/12/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202406
- Publication date:
- 07/02/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202406
- Publication date:
- 07/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|